CHLORPROMAZINE MARKET

INTRODUCTIONCHLORPROMAZINE MARKET

 A common brand name for the antipsychotic drug chlorpromazine (CPZ) are Thorazine and Largactil.Psychotic illnesses like schizophrenia are the main conditions it is used to treat.

Additional applications include the treatment of bipolar disorder, severe behavioural issues in kids, such as those caused by attention deficit hyperactivity disorder, nausea and vomiting, anxiety before surgery, and hiccups that do not go away after trying other remedies.

It can be administered orally (by mouth), intravenously (by injection into a vein), or intramuscularly (in an area of the muscle) (injection into a vein).

The typical antipsychotic class includes chlorpromazine, which chemically belongs to the phenothiazines. Its exact mode of action is unknown, although it is thought to be connected to its capacity as a dopamine antagonist.

Additionally, it contains antihistaminergic and antiserotonergic effects.An antipsychotic drug called chlorpromazine is used to treat schizophrenia, mania, psychosis, and anxiety. Injections: This 25 mg, 1 ml, short-acting injectable is available.

Chlorpromazine belongs to the group of drugs known as conventional antipsychotics. It functions by altering how some natural compounds behave in the brain and other bodily regions.

CHLORPROMAZINE MARKET SIZE AND FORECAST

The Global CHLORPROMAZINE market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

CHLORPROMAZINE MARKETNEW PRODUCT LAUNCH

An antipsychotic drug called chlorpromazine is used to treat schizophrenia, mania, psychosis, and anxiety. Anticholinergic medications may lessen the antipsychotic effects of chlorpromazine, while additional anticholinergic medications may intensify the moderate anticholinergic effects of chlorpromazine, perhaps causing diarrhoea, heat stroke, etc.

Chlorpromazine may counteract the effects of various medications, including amphetamine, levodopa, clonidine, guanethidine, and adrenaline.

Chlorpromazine Hydrochloride Tablets, USP, 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg, according to Lannett Company, Inc. The U.S. Food and Drug Administration (FDA) recently approved the company's Abbreviated New Drug Application (ANDA).

The internally manufactured medication Chlorpromazine Hydrochloride Tablets is used to treat adult patients with psychotic disorders like schizophrenia or manic-depression.

The reference stated medication Thorazine® Tablets 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg of GlaxoSmithKline are therapeutically comparable to Chlorpromazine Hydrochloride Tablets, USP, 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg.

CHLORPROMAZINE MARKETCOMPANY PROFILE

• EMC
• NIH
• GMP
• MAYO
• ANAFRANIL

THISCHLORPROMAZINE MARKETREPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many chlorpromazines are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global chlorpromazine and key vendor selection criteria
3. Where is the chlorpromazine manufactured? What is the average margin per unit?
4. Market share of Global chlorpromazine market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global chlorpromazine in-house
6. key predictions for next 5 years in Global chlorpromazine market
7. Average B-2-B chlorpromazine market price in all segments
8. Latest trends in chlorpromazine market, by every market segment
9. The market size (both volume and value) of the chlorpromazine market in 2024-2030 and every year in between?
10. Production breakup of chlorpromazine market, by suppliers and their OEM relationship